Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Loading...

Wednesday, 13 January 2021

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections : Public Support for Legalization...